Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gastrointestinal factors in autistic disorder: a critical review.

Literature DB >> 16267642

Gastrointestinal factors in autistic disorder: a critical review.

Craig A Erickson¹, Kimberly A Stigler, Mark R Corkins, David J Posey, Joseph F Fitzgerald, Christopher J McDougle.

Abstract

Interest in the gastrointestinal (GI) factors of autistic disorder (autism) has developed from descriptions of symptoms such as constipation and diarrhea in autistic children and advanced towards more detailed studies of GI histopathology and treatment modalities. This review attempts to critically and comprehensively analyze the literature as it applies to all aspects of GI factors in autism, including discussion of symptoms, pathology, nutrition, and treatment. While much literature is available on this topic, a dearth of rigorous study was found to validate GI factors specific to children with autism.

Entities: Disease Species

Mesh：

Year: 2005 PMID： 16267642 DOI： 10.1007/s10803-005-0019-4

Source DB: PubMed Journal: J Autism Dev Disord ISSN： 0162-3257

62 in total

1. Improved social and language skills after secretin administration in patients with autistic spectrum disorders.

Authors: K Horvath; G Stefanatos; K N Sokolski; R Wachtel; L Nabors; J T Tildon
Journal: J Assoc Acad Minor Phys Date: 1998

2. Toddler diarrhoea: more a nutritional disorder than a disease.

Authors: J H Hoekstra
Journal: Arch Dis Child Date: 1998-07 Impact factor: 3.791

Review 3. Autism and gastrointestinal symptoms.

Authors: Karoly Horvath; Jay A Perman
Journal: Curr Gastroenterol Rep Date: 2002-06

4. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.

Authors: S J Coniglio; J D Lewis; C Lang; T G Burns; R Subhani-Siddique; A Weintraub; H Schub; E W Holden
Journal: J Pediatr Date: 2001-05 Impact factor: 4.406

Review 5. Secretin treatment for autistic disorder: a critical analysis.

Authors: Nick C Patel; Jun Y Yeh; Marvin D Shepherd; M Lynn Crismon
Journal: Pharmacotherapy Date: 2002-07 Impact factor: 4.705

6. Pica and elevated blood lead level in autistic and atypical children.

Authors: D J Cohen; W T Johnson; B K Caparulo
Journal: Am J Dis Child Date: 1976-01

7. Disruption of sulphated glycosaminoglycans in intestinal inflammation.

Authors: S H Murch; T T MacDonald; J A Walker-Smith; M Levin; P Lionetti; N J Klein
Journal: Lancet Date: 1993-03-20 Impact factor: 79.321

Review 8. Autistic disorder and gastrointestinal disease.

Authors: Karoly Horvath; Jay A Perman
Journal: Curr Opin Pediatr Date: 2002-10 Impact factor: 2.856

9. Constipation with acquired megarectum in children with autism.

Authors: Nadeem Afzal; Simon Murch; Kumran Thirrupathy; Leslie Berger; Andrew Fagbemi; Robert Heuschkel
Journal: Pediatrics Date: 2003-10 Impact factor: 7.124

10. Minerals in the hair and nutrient intake of autistic children.

Authors: T R Shearer; K Larson; J Neuschwander; B Gedney
Journal: J Autism Dev Disord Date: 1982-03

28 in total

Review 1. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors: Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal: Neuropsychopharmacology Date: 2011-09-21 Impact factor: 7.853

2. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors: Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal: J Child Adolesc Psychopharmacol Date: 2011-11-09 Impact factor: 2.576

3. Autism and coeliac disease.

Authors: Giulia Barcia; Annio Posar; Margherita Santucci; Antonia Parmeggiani
Journal: J Autism Dev Disord Date: 2007-11-06

4. Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?

Authors: Julie Wilson; Barry Wright; Sandra Jost; Robert Smith; Helen Pearce; Sally Richardson
Journal: Pediatr Res Date: 2016-11-23 Impact factor: 3.756

5. Development and validation of an inventory to assess mealtime behavior problems in children with autism.

Authors: Colleen Taylor Lukens; Thomas R Linscheid
Journal: J Autism Dev Disord Date: 2007-06-20

6. A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.

Authors: Benjamin L Handen; Raun D Melmed; Robin L Hansen; Michael G Aman; David L Burnham; Jon B Bruss; Christopher J McDougle
Journal: J Autism Dev Disord Date: 2009-01-16

7. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.

Authors: Tewarit Sarachana; Rulun Zhou; Guang Chen; Husseini K Manji; Valerie W Hu
Journal: Genome Med Date: 2010-04-07 Impact factor: 11.117

Review 8. Immune dysregulation in autism spectrum disorder.

Authors: Daniela Briceno Noriega; Huub F J Savelkoul
Journal: Eur J Pediatr Date: 2013-12-03 Impact factor: 3.183

9. Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism.

Authors: Jacobine E Buizer-Voskamp; Lude Franke; Wouter G Staal; Emma van Daalen; Chantal Kemner; Roel A Ophoff; Jacob As Vorstman; Herman van Engeland; Cisca Wijmenga
Journal: Eur J Hum Genet Date: 2009-11-25 Impact factor: 4.246

10. Low Serum Alpha-1 Antitrypsin (AAT) in Family Members of Individuals with Autism Correlates with PiMZ Genotype.

Authors: Anthony J Russo; Lauren Neville; Christine Wroge
Journal: Biomark Insights Date: 2009-03-18